Open access
86
Views
2
CrossRef citations to date
0
Altmetric
Original Research
Early Clinically Important Improvement (ECII) and Exacerbation Outcomes in COPD Patients
Konstantinos Kostikas1 Respiratory Medicine Department, University of Ioannina Medical School, Ioannina, GreeceCorrespondence[email protected]
https://orcid.org/0000-0003-0774-3942
Alexander J Mackay2 National Heart and Lung Institute, Imperial College London, London, UK
, Claus F Vogelmeier3 Department of Medicine, Pulmonary and Critical Care Medicine, Philipps-Universität Marburg, Member of the German Center for Lung Research (DZL), Marburg, Germany
, Stefan-Marian Frent4 Department of Pulmonology, University of Medicine and Pharmacy Timisoara, Timisoara, Romania
https://orcid.org/0000-0002-7469-6755
Pritam Gupta5 Novartis Healthcare Pvt. Ltd., Hyderabad, India
, Donald Banerji6 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
, Francesco Patalano7 Novartis Pharma AG, Basel, Switzerland
https://orcid.org/0000-0001-7015-6084
Pascal J Pfister7 Novartis Pharma AG, Basel, Switzerland
https://orcid.org/0000-0002-2276-5042
Jadwiga A Wedzicha8 Respiratory Clinical Science Section, National Heart and Lung Institute, Imperial College London, London, UK
show all
Pages 1831-1838
|
Published online: 28 Jul 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.